Social Anxiety Disorder
Conditions
Keywords
Community Sample
Brief summary
The aim of this study is to evaluate the feasibility and initial efficacy of an enhanced mindfulness-based program that includes mindful exposure to reduce anxiety and avoidance of social situations, and the Buddhist practice of self-compassion aimed at reducing harsh judgment and self-criticism that is characteristic of people with social anxiety disorder.
Detailed description
The purpose of this pilot study is to evaluate the feasibility and initial efficacy of an enhanced mindfulness-based intervention for SAD (MIND-SAD) that incorporates the following components: training in classical mindfulness, including concentration and insight (vipassana) meditation; training in self-compassion; and mindful exposure. An exploratory aim of the study is to evaluate the effects of the mindfulness intervention on biological markers of stress reactivity, including salivary cortisoland salivary alpha-amylase. The study is a two-arm, parallel design, prospective study comparing 12 weekly sessions of MIND-SAD delivered in a group format versus a wait-list control (WLC).
Interventions
BEHAVIORALMindfulness Meditation
Sponsors
Hopital Montfort
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Primary diagnosis of Social Anxiety Disorder; Baseline score of 30 or higher on the Liebowitz Social Anxiety Scale; Baseline score of 4 or higher on the Clinical Global Impression of Severity
Exclusion criteria
* Lifetime history of psychosis or bipolar disorder; substance abuse in the past 12 months; diagnosis of borderline or antisocial personality disorder; serious suicide risk; currently in psychotherapy; regular meditation or yoga practice in the past 12 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Social Phobia Inventory | change from baseline at weeks 6, 12 and 3 months follow-up |
| Clinician-rated Liebowitz Social Phobia Scale | change from baseline at weeks 6, 12 and 3 months follow-up |
Secondary
| Measure | Time frame |
|---|---|
| Social Adjustment Scale-Self-Report | change from baseline at weeks 6 and 12 and 3 months follow-up |
| CGI-Severity of Illness | change from baseline at weeks 6, 12 and 3 months follow-up |
| Beck Depression Inventory | change from baseline at weeks 6, 12 and 3 months follow-up |
| Self-Compassion Scale | change from baseline at weeks 6, 12 and 3-months follow-up |
| Five Facet Mindfulness Questionnaire | change from baseline at weeks 6, 12 and 3 months follow-up |
Other
| Measure | Time frame |
|---|---|
| Salivary cortisol | change from baseline at week 12 |
| Study compliance: attendance and homework | compliance will be assessed at each week during the 12-week mndfulness meditation program |
| Salivary alpha-amylase | change from baseline at week 12 |
Countries
Canada
Outcome results
None listed